{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:29:10Z","timestamp":1793125750599,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical Training Foundation of Southern Medical University","award":["LC2019ZD026"],"award-info":[{"award-number":["LC2019ZD026"]}]},{"name":"the Scientific Research Foundation of the Guangdong Second Provincial General Hospital","award":["YY2024-011"],"award-info":[{"award-number":["YY2024-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47772-4","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:46:15Z","timestamp":1775655975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alpha-1 antitrypsin as a new biomarker of inflammation, infection and disease severity in community-acquired pneumonia: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Siqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuna","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"47772_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(16)30267-5","author":"A Stefano","year":"2016","unstructured":"Stefano, A. et al. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): An international, observational cohort study. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/s1473-3099(16)30267-5 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"47772_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0183-2024","author":"N Natsuki","year":"2025","unstructured":"Natsuki, N. et al. Risk factors for drug-resistant pathogens in community-acquired pneumonia: Systematic review and meta-analysis. Eur. Respir. Rev. https:\/\/doi.org\/10.1183\/16000617.0183-2024 (2025).","journal-title":"Eur. Respir. Rev."},{"key":"47772_CR3","unstructured":"Centers for Disease Control and Prevention. FastStats - Pneumonia. https:\/\/www.cdc.gov\/nchs\/fastats\/pneumonia.htm. Accessed February 6 (2020)."},{"key":"47772_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02487-6","author":"G Xue","year":"2025","unstructured":"Xue, G. et al. Glucocorticoids can reduce mortality in patients with severe community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. Eur. J. Med. Res. https:\/\/doi.org\/10.1186\/s40001-025-02487-6 (2025).","journal-title":"Eur. J. Med. Res."},{"key":"47772_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.004","author":"S Yixin","year":"2020","unstructured":"Yixin, S. et al. Incidence of community-acquired pneumonia in urban China: A national population-based study. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.004 (2020).","journal-title":"Vaccine"},{"key":"47772_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100968","author":"F Guohui","year":"2023","unstructured":"Guohui, F. et al. The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. Lancet Reg. Health West Pac. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100968 (2023).","journal-title":"Lancet Reg. Health West Pac."},{"key":"47772_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00630-9","author":"A Stefano","year":"2021","unstructured":"Stefano, A., Charles S, D. C., Francesco, A., Giovanni, S. & Marcos I, R. Community-acquired pneumonia. Lancet https:\/\/doi.org\/10.1016\/s0140-6736(21)00630-9 (2021).","journal-title":"Lancet"},{"key":"47772_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00015-22","author":"NJ Gadsby","year":"2022","unstructured":"Naomi, J. G. & Daniel. M. M. The microbial etiology of community-acquired pneumonia in adults: From classical bacteriology to host transcriptional signatures. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00015-22 (2022).","journal-title":"Clin. Microbiol. Rev."},{"key":"47772_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00259-0","author":"T Antoni","year":"2021","unstructured":"Antoni, T. et al. Pneumonia. Nat. Rev. Dis. Primers https:\/\/doi.org\/10.1038\/s41572-021-00259-0 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"47772_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245","author":"J Seema","year":"2015","unstructured":"Seema, J. et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1500245 (2015).","journal-title":"N. Engl. J. Med."},{"key":"47772_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00096-2018","author":"C Manuela","year":"2018","unstructured":"Manuela, C. et al. Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study. ERJ. Open Res. https:\/\/doi.org\/10.1183\/23120541.00096-2018 (2018).","journal-title":"ERJ. Open Res."},{"key":"47772_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-020-00074-3","author":"S Saeed","year":"2020","unstructured":"Saeed, S. & Daniel, M. M. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia Nathan https:\/\/doi.org\/10.1186\/s41479-020-00074-3 (2020).","journal-title":"Pneumonia Nathan"},{"key":"47772_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443297","author":"M Carmen","year":"2024","unstructured":"Carmen, M. et al. Immunological and homeostatic pathways of alpha -1 antitrypsin: A new therapeutic potential. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1443297 (2024).","journal-title":"Front. Immunol."},{"key":"47772_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00269-3","author":"J Ewa","year":"2021","unstructured":"Ewa, J. et al. Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-021-00269-3 (2021).","journal-title":"Gene Ther."},{"key":"47772_CR15","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1293_19","author":"M Kunder","year":"2022","unstructured":"Kunder, M., Lakshmaiah, V. & Moideen Kutty, A. V. Selective decrease in alpha1-antitrypsin levels in diabetic retinopathy: Could the levels of it be playing a role in the pathophysiology of diabetic retinopathy?. Indian J. Med. Res. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1293_19 (2022).","journal-title":"Indian J. Med. Res."},{"key":"47772_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060807","author":"JL Lopez-Campos","year":"2025","unstructured":"Lopez-Campos, J. L., Munoz-Sanchez, B., Ferrer-Galvan, M. & Quintana-Gallego, E. Alpha-1 antitrypsin deficiency and bronchial asthma: Current challenges. Biomolecules https:\/\/doi.org\/10.3390\/biom15060807 (2025).","journal-title":"Biomolecules"},{"key":"47772_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05059-1","author":"D Andrea","year":"2023","unstructured":"Andrea, D. et al. Probing of the reactive center loop region of alpha-1-antitrypsin by mutagenesis predicts new type-2 dysfunctional variants. Cell. Mol. Life Sci. https:\/\/doi.org\/10.1007\/s00018-023-05059-1 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"47772_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.01.039","author":"EO Victor","year":"2025","unstructured":"Victor, E. O. et al. \u03b11-Antitrypsin gene variation associates with asthma exacerbations and related health care utilization. J. Allergy Clin. Immunol. Pract. https:\/\/doi.org\/10.1016\/j.jaip.2025.01.039 (2025).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"47772_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2017.1401600","author":"LS Christopher","year":"2018","unstructured":"Christopher, L. S., Amy, P. & Friedrich, K. The effects of inflammation on alpha 1 antitrypsin levels in a national screening cohort. COPD https:\/\/doi.org\/10.1080\/15412555.2017.1401600 (2018).","journal-title":"COPD"},{"key":"47772_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021144","author":"Z Natalya","year":"2023","unstructured":"Natalya, Z., Yulia, Z., Valeriy, C. & Evgenii, G. Acute and chronic systemic inflammation: Features and differences in the pathogenesis, and integral criteria for verification and differentiation. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24021144 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"47772_CR21","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0515OC","author":"DL Angelia D","year":"2013","unstructured":"Angelia, D. L. et al. \u03b11-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-\u03b1. Am. J. Respir. Cell Mol. Biol. https:\/\/doi.org\/10.1165\/rcmb.2012-0515OC (2013).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"47772_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020088","author":"X Siyu","year":"2025","unstructured":"Siyu, X. et al. Alpha-1 Antitrypsin as a regulatory protease inhibitor modulating inflammation and shaping the tumor microenvironment in cancer. Cells https:\/\/doi.org\/10.3390\/cells14020088 (2025).","journal-title":"Cells"},{"key":"47772_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12694","author":"Y Ye","year":"2017","unstructured":"Ye, Y. et al. Anti-inflammaging effects of human alpha-1 antitrypsin. Aging Cell https:\/\/doi.org\/10.1111\/acel.12694 (2017).","journal-title":"Aging Cell"},{"key":"47772_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.995869","author":"J Sabina","year":"2022","unstructured":"Sabina, J. et al. Indirect effect of alpha-1-antitrypsin on endotoxin-induced IL-1\u03b2 secretion from human PBMCs. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.995869 (2022).","journal-title":"Front. Pharmacol."},{"key":"47772_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29204951","author":"MH Naiera","year":"2024","unstructured":"Naiera, M. H. & Keykavous, P. The role of peptides in combatting HIV infection: Applications and insights. Molecules https:\/\/doi.org\/10.3390\/molecules29204951 (2024).","journal-title":"Molecules"},{"key":"47772_CR26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0311com","author":"L Shapiro","year":"2001","unstructured":"Shapiro, L., Pott, G. B. & Ralston, A. H. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. https:\/\/doi.org\/10.1096\/fj.00-0311com (2001).","journal-title":"FASEB J."},{"key":"47772_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2022.03.001","author":"JM Oliver","year":"2022","unstructured":"Oliver, J. M. et al. A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19. Med https:\/\/doi.org\/10.1016\/j.medj.2022.03.001 (2022).","journal-title":"Med"},{"key":"47772_CR28","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-0920","author":"S Franziska","year":"2024","unstructured":"Franziska, S., Daniel, S., Daniel, T.-R., Michael, B. & Michael, K. C-terminal alpha-1-antitrypsin peptides as novel predictor of hospital mortality in critically ill COVID-19 patients. Clin. Chem. Lab. Med. https:\/\/doi.org\/10.1515\/cclm-2024-0920 (2024).","journal-title":"Clin. Chem. Lab. Med."},{"key":"47772_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-017-0658-1","author":"M Kunder","year":"2018","unstructured":"Kunder, M., Lakshmaiah, V. & Moideen Kutty, A. V. Plasma Neutrophil Elastase, \u03b11-Antitrypsin, \u03b12-Macroglobulin and Neutrophil Elastase-\u03b11-Antitrypsin Complex levels in patients with Dengue Fever. Indian J. Clin. Biochem. https:\/\/doi.org\/10.1007\/s12291-017-0658-1 (2018).","journal-title":"Indian J. Clin. Biochem."},{"key":"47772_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04447-5","author":"R Sandipan","year":"2017","unstructured":"Sandipan, R. et al. Quantitative proteomics analysis of Plasmodium vivax induced alterations in human serum during the acute and convalescent phases of infection. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-04447-5 (2017).","journal-title":"Sci. Rep."},{"key":"47772_CR31","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1001-0939.2016.04.001","author":"JM Qu","year":"2016","unstructured":"Qu, J. M. & Cao, B. Guidelines for the diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition). Zhonghua Jie He He Hu Xi Za Zhi https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2016.04.001 (2016).","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"47772_CR32","doi-asserted-by":"publisher","DOI":"10.1086\/589754","author":"PGP Charles.","year":"2008","unstructured":"Charles, P. G. P. et al. SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin. Infect. Dis. https:\/\/doi.org\/10.1086\/589754 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"47772_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00051-2023","author":"AG Kaal","year":"2023","unstructured":"Kaal, A. G. et al. Outcomes of community-acquired pneumonia using the Pneumonia Severity Index versus the CURB-65 in routine practice of emergency departments. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00051-2023 (2023).","journal-title":"ERJ Open Res."},{"key":"47772_CR34","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00420-2024","author":"F Imrana","year":"2024","unstructured":"Imrana, F. et al. Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00420-2024 (2024).","journal-title":"ERJ Open Res."},{"key":"47772_CR35","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2018.23.3.131","author":"K Minsun","year":"2018","unstructured":"Minsun, K., Qing, C. & Youngman, O. Therapeutic potential of alpha-1 antitrypsin in human disease. Ann. Pediatr. Endocrinol. Metab. https:\/\/doi.org\/10.6065\/apem.2018.23.3.131 (2018).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"47772_CR36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13472","author":"W Tiantian","year":"2025","unstructured":"Tiantian, W. et al. \u03b1\u20111 antitrypsin is a potential target of inflammation and immunomodulation (review). Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2025.13472 (2025).","journal-title":"Mol. Med. Rep."},{"key":"47772_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16342","author":"G Wenyu","year":"2020","unstructured":"Wenyu, G. et al. Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation. Am. J. Transplant. https:\/\/doi.org\/10.1111\/ajt.16342 (2020).","journal-title":"Am. J. Transplant"},{"key":"47772_CR38","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0208145","author":"BP Gregory","year":"2009","unstructured":"Gregory B, P., Edward D, C., Charles A, D. & Leland, S. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc Biol. https:\/\/doi.org\/10.1189\/jlb.0208145 (2009).","journal-title":"J. Leukoc Biol."},{"key":"47772_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00199","author":"AN Dabrowski","year":"2019","unstructured":"Dabrowski, A. N. et al. Peptidoglycan Recognition Protein 2 regulates neutrophil recruitment into the lungs after Streptococcus pneumoniae infection. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.00199 (2019).","journal-title":"Front. Microbiol."},{"key":"47772_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01643-24","author":"EVK Ledger","year":"2024","unstructured":"Ledger, E. V. K. & Edwards, A. M. Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils. MBio https:\/\/doi.org\/10.1128\/mbio.01643-24 (2024).","journal-title":"MBio"},{"key":"47772_CR41","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9702033","author":"DL Knoell","year":"1998","unstructured":"Knoell, D. L., Ralston, D. R., Coulter, K. R. & Wewers, M. D. Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/ajrccm.157.1.9702033 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47772-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:12:43Z","timestamp":1780009963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47772-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47772-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of The Third Affiliated Hospital, Southern Medical University (Approval No. 2022-lunshen-046). Written informed consent was obtained from the legal guardians of all participants. This research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"16640"}}